17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma

This study has been completed.

Study NCT00004241. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004241

Locations


United States, Pennsylvania
	Hillman Cancer Center at University of Pittsburgh Cancer Institute
	Pittsburgh, Pennsylvania, United States, 15232

Sponsors and Collaborators

UPMC Cancer Centers

National Cancer Institute (NCI)

Investigators


Study Chair:	Ramesh K. Ramanathan, MD	UPMC Cancer Centers